Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Role of MRI in Neoadjuvant Chemotherapy for Bladder Cancer

NCT01922232 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01922232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01922232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Role of MRI in Neoadjuvant Chemotherapy for Bladder Cancer
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Withdrawn
Start date
August 31, 2013
Completion date
July 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive bladder cancer